Tobacco cessation within TB programmes: A ‘real world’ solution for countries with dual burden of disease

null

TB and Tobacco is a four-year project, funded by the European Union’s Horizon 2020 research and innovation programme. 

The project is coordinated by the University of York (Department of Health Sciences) and involves eight other partners: ARK Foundation, Dhaka, Bangladesh; HERD International Pvt. Ltd., Kathmandu, Nepal; National TB Programme, Islamabad, Pakistan; The Initiative, Islamabad, Pakistan; Heinrich-Heine University, Düsseldorf, Germany; the University of Edinburgh, UK; the University of Leeds, UK and the General University Hospital, Prague, Czech Republic.

The aim of the project is to investigate ways in which interventions designed to encourage people to stop smoking can be integrated into tuberculosis (TB) control programmes. Our ultimate goal is to improve the health and longevity of patients suffering from TB, as well as decreasing the number of people who suffer from tobacco-related diseases.

The research is centred on three countries that have high incidence of tobacco use and high prevalence of TB, namely Bangladesh, Nepal and Pakistan.

By studying the ‘real world’ influences on the implementation and success of stopping smoking in these contexts, the investigators hope to translate the findings of the study into real benefits for patients. 

This project has received funding from the European Union's Horizon 2020 research and innovation programme, under grant agreement number 680995.
The European Commission is not responsible for any of the content of this website.

Privacy Notice: How we use your research data